logo

Hepatitis C

2nd HCV Policy Summit on the elimination of hepatitis C in Europe

Securing sustainable funding for Hepatitis C Virus elimination plans

Programme

2nd EU HCV Summit “Securing sustainable funding for HCV elimination plans”
6th June 2018 11:30 to 18:00
Steigenberger Wiltcher’s, Brussels, Belgium

11:30 - 12:00

Registration and welcoming coffee

12:00 - 12:30 Welcome and introduction
Chair: Prof. Angelos Hatzakis, Prof. Michael Manns

 

Welcome to event and scene setting

Prof. Michael P. Manns, Co-Chair, Hepatitis B&C Public Policy Association

Prof. Angelos Hatzakis, Co-Chair, Hepatitis B&C Public Policy Association 

 

“MEP Friends of the Liver Group”

 Dr. Cristian-Silviu Buşoi, Member of the European Parliament and Co-Chair of the Friends of the Liver MEP Group 

 

“European Liver Patients’ Association”

 Dr. Tatjana Reic, President of the European Liver Patients’ Association, Chair of ACHIEVE Coalition 

 

“EASL’s actions to achieve HCV Elimination in Europe”

 Prof. Francesco Negro, Educational Councillor, European Association for the Study of Liver 

 

“European Civil Society Forum”

Eberhard Schatz, Coordinator CORRELATION Network & European Civil Society Forum 

 

12:30 - 13:10

Session 1: Burden of disease and pathways of elimination

Chair: Prof. Georgios Papatheodoridis, Prof. Mojca Maticic 

 

“HCV Elimination in Europe: Burden Pathways and Cost”

Dr. Homie Razavi, Managing Director,

The Centre for Disease Analysis Foundation

 

“The micro-elimination approach to eliminating hepatitis”

 Prof. Jeffrey Lazarus, Associate Professor, University of Barcelona, ISGlobal 

 

“WHO-EURO: Progress Report”

 Dr. Antons Mozalevskis, Medical Officer, WHO Regional Office for Europe 

 

13:10 - 13:30 Questions & answers
13:30 - 14:00 Lunch break
14:00 - 14:15

Keynote address

Chair: Prof. Meni Malliori

 

“Policy actions to secure long-term funding for hepatitis elimination”
President George A. Papandreou, President of the Socialist International, Former Prime Minister of Greece

14:15 - 15:05

Session 2: The cost of HCV Elimination

Chair: Prof. Francesco Negro, Prof. Sharon Hutchinson

 

“Cost of HCV elimination: Direct medical cost, patients reported outcomes and productivity loss”

Dr. Zobair Younossi, Chairman, Department of Medicine, Inova Fairfax Medical Campus 

“Cost of screening”

Prof. Sylvie Deufic-Burban, French National Institute of Health and Medical Research (INSERM) 

"Price tag for bringing hepatitis B and C services under the umbrella of Universal Health Coverage"

Dr. David Tordrup, WHO Consultant, WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University 

“Is hepatitis elimination cost saving?”

Prof. Jagpreet Chhatwal, Assistant Professor, Harvard Medical School 

15:05 - 15:25

Questions and Answers

15:25 - 15:45

Coffee break

15:45 - 16:20

Session 3: Innovative financing

Chairs: Prof. Markus Peck-Radosavljevic, Prof. Dr. Nurdan Tözün

“Innovative financing of HCV Elimination”

Prof. Jagpreet Chhatwal, Assistant Professor, Harvard Medical School 

“Financing solutions for hepatitis elimination in low and middle income countries”

Dr. Homie Razavi, Managing Director, The Centre for Disease Analysis Foundation

16:20 - 16:40

Questions& answers

16:4017:20

Session 4: Opportunities and challenges

Chairs: Prof. Gamal Esmat, Prof. Dr. Charles Boucher

 

“ACHIEVE-Association Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe”

Dr. Tatjana Reic, President of the European Liver Patients Association, Chair of ACHIEVE Coalition 

 

“European Civil Society Forum”

Eberhard Schatz, Coordinator, CORRELATION network & European Civil Society Forum

 

“Hepatitis C: Political leadership for elimination”

Dr. Ricardo Baptista Leite, Member of Portuguese Parliament 

17:20 – 17:40

Questions& answers

17:40 – 18:00

Wrap-up

Next steps & invitation to Call to Action

Prof. Jeffrey Lazarus, Associate Professor, University of Barcelona, ISGlobal 

Prof. Angelos Hatzakis, Co-Chair, Hepatitis B&C Public Policy Association 

The 2nd high-level European Policy Summit on the elimination of the Hepatitis C Virus (HCV) in Europe is being organised by the Hepatitis B&C Public Policy Association.

The HCV Policy Summit will take place on Wednesday, 6th June 2018 from 11.30pm to 6.30pm.

The venue for the Summit is the Steigenberger Wiltcher’s Hotel, 71 Avenue Louise, 1050 Brussels. For more information about the Steigenberger Wiltcher’s Hotel please see the link Venue. This hotel is also where the Summit attendees will be accommodated.

A buffet lunch will be offered at an interval of the Summit.

Participation at the Summit is by invitation only. If you would like to attend this event, please send an email to the Summit Administrative Secretariat: Ms Ann Fox at afox@hepbcppa.org

Please note that registration for the Summit is not possible on this website.

With financial support of

Official endorsements